Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seizures | 24 | 2024 | 2957 | 3.690 |
Why?
|
Subarachnoid Hemorrhage | 13 | 2024 | 1033 | 2.420 |
Why?
|
Electroencephalography | 35 | 2024 | 6237 | 2.300 |
Why?
|
Anticonvulsants | 9 | 2024 | 1906 | 1.460 |
Why?
|
Brain Ischemia | 13 | 2022 | 3049 | 1.120 |
Why?
|
Status Epilepticus | 8 | 2024 | 460 | 1.060 |
Why?
|
Critical Illness | 7 | 2024 | 2723 | 1.030 |
Why?
|
Critical Care | 7 | 2024 | 2697 | 0.940 |
Why?
|
Electronic Health Records | 9 | 2024 | 4811 | 0.840 |
Why?
|
Glasgow Outcome Scale | 2 | 2018 | 104 | 0.750 |
Why?
|
Natural Language Processing | 3 | 2024 | 1163 | 0.660 |
Why?
|
Reflex, Pupillary | 2 | 2022 | 62 | 0.650 |
Why?
|
Epilepsy | 9 | 2024 | 3290 | 0.560 |
Why?
|
Inpatients | 2 | 2023 | 2548 | 0.470 |
Why?
|
Pupil Disorders | 1 | 2014 | 32 | 0.450 |
Why?
|
Monitoring, Physiologic | 5 | 2023 | 1779 | 0.400 |
Why?
|
West Nile Fever | 1 | 2012 | 75 | 0.390 |
Why?
|
Myelitis | 1 | 2012 | 49 | 0.390 |
Why?
|
West Nile virus | 1 | 2012 | 77 | 0.390 |
Why?
|
Stroke | 4 | 2024 | 9758 | 0.380 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2014 | 251 | 0.380 |
Why?
|
Cost of Illness | 1 | 2021 | 1936 | 0.380 |
Why?
|
Moyamoya Disease | 1 | 2014 | 265 | 0.370 |
Why?
|
Brain | 8 | 2023 | 27120 | 0.330 |
Why?
|
Muscle Weakness | 1 | 2012 | 412 | 0.320 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2014 | 710 | 0.320 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 882 | 0.320 |
Why?
|
Retrospective Studies | 22 | 2024 | 80646 | 0.310 |
Why?
|
Consensus | 2 | 2024 | 3123 | 0.300 |
Why?
|
Cerebral Hemorrhage | 2 | 2021 | 2656 | 0.290 |
Why?
|
Brain Injuries | 3 | 2024 | 2053 | 0.290 |
Why?
|
Upper Extremity | 1 | 2012 | 658 | 0.280 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2578 | 0.270 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15843 | 0.270 |
Why?
|
Propofol | 2 | 2024 | 603 | 0.270 |
Why?
|
Middle Aged | 31 | 2024 | 220920 | 0.260 |
Why?
|
Intensive Care Units | 7 | 2022 | 3744 | 0.260 |
Why?
|
Aged | 25 | 2024 | 169310 | 0.250 |
Why?
|
Humans | 64 | 2024 | 761572 | 0.240 |
Why?
|
Male | 34 | 2024 | 360842 | 0.230 |
Why?
|
Patient Discharge | 3 | 2023 | 3443 | 0.220 |
Why?
|
Brain Waves | 2 | 2018 | 409 | 0.210 |
Why?
|
Female | 34 | 2024 | 392686 | 0.210 |
Why?
|
Anisocoria | 1 | 2022 | 9 | 0.200 |
Why?
|
Brain Diseases | 2 | 2021 | 1545 | 0.190 |
Why?
|
Sturge-Weber Syndrome | 1 | 2022 | 89 | 0.180 |
Why?
|
Cerebral Infarction | 3 | 2022 | 983 | 0.180 |
Why?
|
Adult | 24 | 2024 | 221203 | 0.170 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.170 |
Why?
|
Reference Standards | 2 | 2021 | 1003 | 0.170 |
Why?
|
Data Mining | 1 | 2024 | 551 | 0.170 |
Why?
|
Diuretics, Osmotic | 1 | 2019 | 33 | 0.160 |
Why?
|
Vasospasm, Intracranial | 1 | 2021 | 215 | 0.160 |
Why?
|
International Classification of Diseases | 2 | 2022 | 909 | 0.160 |
Why?
|
Saline Solution, Hypertonic | 1 | 2019 | 114 | 0.160 |
Why?
|
Mannitol | 1 | 2019 | 180 | 0.160 |
Why?
|
Cohort Studies | 6 | 2024 | 41493 | 0.150 |
Why?
|
Pupil | 1 | 2019 | 146 | 0.150 |
Why?
|
Epilepsy, Post-Traumatic | 1 | 2018 | 40 | 0.150 |
Why?
|
Aftercare | 1 | 2024 | 914 | 0.150 |
Why?
|
Tachycardia | 1 | 2020 | 600 | 0.140 |
Why?
|
Medicare Part C | 1 | 2022 | 334 | 0.140 |
Why?
|
Dementia | 2 | 2022 | 2689 | 0.140 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2016 | 46 | 0.140 |
Why?
|
Fever | 1 | 2024 | 1618 | 0.130 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2016 | 65 | 0.130 |
Why?
|
Medical History Taking | 1 | 2020 | 774 | 0.130 |
Why?
|
Algorithms | 5 | 2024 | 14032 | 0.120 |
Why?
|
Thrombectomy | 1 | 2020 | 705 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2023 | 64684 | 0.120 |
Why?
|
Brain Edema | 1 | 2019 | 604 | 0.120 |
Why?
|
Anesthetics | 1 | 2020 | 523 | 0.120 |
Why?
|
Scalp | 1 | 2017 | 389 | 0.120 |
Why?
|
Massachusetts | 2 | 2024 | 8830 | 0.110 |
Why?
|
Automation | 1 | 2016 | 586 | 0.110 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2017 | 389 | 0.110 |
Why?
|
Texas | 1 | 2014 | 404 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2020 | 1530 | 0.110 |
Why?
|
Iris | 1 | 2014 | 232 | 0.100 |
Why?
|
Prognosis | 3 | 2020 | 29629 | 0.100 |
Why?
|
Adolescent | 7 | 2024 | 88324 | 0.100 |
Why?
|
Hospitals, Urban | 1 | 2014 | 500 | 0.100 |
Why?
|
Models, Neurological | 1 | 2020 | 1769 | 0.100 |
Why?
|
Alzheimer Disease | 2 | 2023 | 8601 | 0.100 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1998 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2064 | 0.090 |
Why?
|
Early Diagnosis | 1 | 2016 | 1186 | 0.090 |
Why?
|
Hospital Mortality | 2 | 2023 | 5293 | 0.090 |
Why?
|
Delirium | 1 | 2022 | 1668 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3271 | 0.080 |
Why?
|
Antipsychotic Agents | 1 | 2022 | 3067 | 0.080 |
Why?
|
Organ Size | 1 | 2014 | 2254 | 0.080 |
Why?
|
Cerebral Angiography | 1 | 2014 | 1281 | 0.080 |
Why?
|
Physical Therapy Modalities | 1 | 2012 | 532 | 0.080 |
Why?
|
Immunotherapy | 1 | 2024 | 4652 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4793 | 0.080 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1285 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2023 | 20099 | 0.080 |
Why?
|
Prospective Studies | 6 | 2021 | 54426 | 0.070 |
Why?
|
Periodicity | 2 | 2021 | 348 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10212 | 0.070 |
Why?
|
Quality Improvement | 1 | 2022 | 3801 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10721 | 0.070 |
Why?
|
Electrocardiography | 1 | 2020 | 6377 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26127 | 0.070 |
Why?
|
Headache | 1 | 2014 | 1256 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2016 | 2169 | 0.060 |
Why?
|
Young Adult | 7 | 2024 | 59255 | 0.060 |
Why?
|
Practice Guidelines as Topic | 2 | 2024 | 7391 | 0.060 |
Why?
|
Phenytoin | 1 | 2024 | 190 | 0.050 |
Why?
|
Models, Statistical | 1 | 2018 | 5079 | 0.050 |
Why?
|
Telemedicine | 1 | 2021 | 3052 | 0.050 |
Why?
|
Seizures, Febrile | 1 | 2024 | 108 | 0.050 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39107 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12975 | 0.050 |
Why?
|
Physician Assistants | 1 | 2024 | 191 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8656 | 0.040 |
Why?
|
Time | 1 | 2022 | 546 | 0.040 |
Why?
|
United States | 6 | 2024 | 72335 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2021 | 281 | 0.040 |
Why?
|
Medicare | 3 | 2022 | 6770 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2022 | 600 | 0.040 |
Why?
|
Solubility | 1 | 2020 | 1091 | 0.040 |
Why?
|
Intracranial Hemorrhages | 1 | 2023 | 822 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36429 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58986 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1835 | 0.030 |
Why?
|
Logistic Models | 2 | 2021 | 13255 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2021 | 1475 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.030 |
Why?
|
Life Expectancy | 1 | 2021 | 1242 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2020 | 2707 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2508 | 0.030 |
Why?
|
Decision Support Systems, Clinical | 1 | 2021 | 1175 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42230 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20571 | 0.020 |
Why?
|
Survival Analysis | 1 | 2023 | 10090 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2366 | 0.020 |
Why?
|
Heart Arrest | 1 | 2020 | 1514 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2630 | 0.020 |
Why?
|
Software | 1 | 2023 | 4434 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5492 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3882 | 0.020 |
Why?
|
Child | 2 | 2024 | 80156 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2021 | 4330 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6992 | 0.020 |
Why?
|
Prevalence | 1 | 2021 | 15732 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2020 | 6485 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 14666 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15266 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 23996 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 74213 | 0.010 |
Why?
|
Concepts
(154)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(66)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_